Karlheinz Peter

发表

Generation of activation-speciﬁc human anti- (cid:1) M (cid:2) 2 single-chain antibodies as potential diagnostic tools and therapeutic agents

N. Bassler, M. Schwarz, Juliana Soosairajah, 2007 .

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).

C. Bode, K. Peter, W. Kübler, 1999, Circulation.

Construction and characterization of a recombinant plasminogen activator composed of an anti‐fibrin single‐chain antibody and low‐molecular‐weight urokinase

C. Bode, K. Peter, C. Hagemeyer, 2004, Journal of thrombosis and haemostasis : JTH.

Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.

M. Little, C. Bode, K. Peter, 2000, Circulation.

Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

M. Olschewski, C. Bode, K. Peter, 2008, Circulation.

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

C. Bode, K. Peter, W. Kübler, 1998, Blood.

Inhibition of platelet activation and aggregation.

C. Bode, K. Peter, I. Ahrens, 2005, Handbook of experimental pharmacology.

Single-chain Antibodies for the Conformation-specific Blockade of Activated Platelet Integrin Α Iib Β 3 Designed by Subtractive Selection from Naïve Human Phage Libraries

M. Little, C. Bode, K. Peter, 2022 .

The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery.

C. Bode, K. Peter, H. Böhrer, 1999, Anesthesia and analgesia.

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.

C. Bode, K. Peter, M. Volkmann, 1999, The American journal of cardiology.